MODIFICATION
R -- RFI World Trade Center Health Program Data Center
- Notice Date
- 7/21/2016
- Notice Type
- Modification/Amendment
- NAICS
- 518210
— Data Processing, Hosting, and Related Services
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Acquisition and Assistance Field Branch (Pittsburgh), Post Office Box 18070, Cochrans Mill Road, Pittsburgh, Pennsylvania, 15236-0070
- ZIP Code
- 15236-0070
- Solicitation Number
- WTCHPDC-2017-00641
- Archive Date
- 6/22/2017
- Point of Contact
- Abbie Jemmott, Phone: 4123866433, Katie L. Oyler, Phone: 412-386-4450
- E-Mail Address
-
ygf3@cdc.gov, ycy4@cdc.gov
(ygf3@cdc.gov, ycy4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- In additional to the information attached to this RFI, please find specific activities that shall be required of this Data Center effort. 1. Receiving, analyzing, and reporting to the WTC Program Administrator on data, in accordance with section 3304, that have been collected and reported to such Data Centers by the corresponding Clinical Centers of Excellence under section 3305(b)(1)(B)(iii) of the Zadroga Act; 2. Collect and maintain research quality database from standardized initial health evaluations and annual medical monitoring exams, including responses to questionnaires and medical testing results (i.e., labs, imaging, spirometry, EKG); 3. Tracking and reporting numbers of members consented for aggregation of data by disease/illness categories on a semi-annual basis to inform the NIOSH research award process; 4. Tracking and reporting numbers of members consented for contact by outside researchers for study recruitment, by disease/illness categories on a semi-annual basis to inform the NIOSH research award process; 5. Preparing, discussing and submitting an annual health surveillance report from the aggregated data from monitoring and cancer screening, in accordance with a proposed report template and methodology approved by the WTC Health Program Administrator; 6. Semi-annual routine analysis of aggregated health data and discussion with Clinical Centers of Excellence (CCEs), other Data Centers (DCs) and the Nationwide Provider Network (NPN) to determine if active surveillance is advised for quality case ascertainment; 7. Conducting active surveillance for selected health conditions identified by analysis of monitoring or other aggregated data and clinical observations from the CCEs, other DCs and the NPN where the level of effort and methodology is pre-approved by the WTC Health Program Administrator - first for concept (and priority), timeline and level-of-efforts, and secondarily for methodology; 8. Conducting special analytical projects where substantial resources are required where level of effort and methodology is pre-approved by the WTC Health Program Administrator; 9. Maintaining IRB approval and information technology support for participating entities performing the standardized protocols involving initial health evaluation and medical monitoring; 10. Collaborating with NIOSH, CCEs/NPN, HPS, HPE contractors and NIOSH's subject matter experts (SMEs) to develop medical quality assurance guidelines, and rectification plans when needed; 11. Assigning a data analyst as the principle DC contact for each corresponding CCE to routinely address operational inquiries that include key retention metrics, medically fragile patients (based on claims), exposure and smoking variables that impact treatment eligibility for certain conditions or risk factors meeting criteria for screening tests, and other issues that may impact CCE scheduling, capacity and clinical quality assurance; 12. Routine collaboration with designated WTC Health Program scientists regarding intensive scientific analysis and active surveillance efforts - with advance notification to align expectations regarding publication intent in advance of stakeholder meetings; 13. NIOSH approved requests by CCEs for adhoc quality improvement and assurance efforts that go beyond the approved core medical quality indicators and operational metrics that assist with clinic scheduling and processing; 14. Coordinating and administering the activities of the WTC Health Program Steering Committees established under section 3302(b), including analytical support when needed for program evaluation work as pre-approved by the WTC Health Program Administrator; and 15. Meeting routinely with the corresponding CCE(s) and the NPN to obtain input on the analysis and reporting of data collected under clause (i) and on the development of monitoring and initial health evaluation protocols, cancer screening, diagnosis and treatment guidelines under clause (ii). See 3305(a)(2)(A)(i) through (vi). 16. Engaging in discussion across the WTC Health Program to guide cancer screening; and for diagnostic and treatment approaches for individuals with WTC-related health condition with respect to section 3305(a)(2)(ii). 17. Making any data collected and reported to a Data Center under Section 3305(b)(1)(B)(iii) available to health researchers and others as provided in the CDC/ATSDR Policy on Public Health Research and Non-Research Data Management dated January 26, 2016 (attached); 18. Collaborating with the WTC Health Registry to evaluate needs for analysis across cohorts for issues suggestive of a condition that may be linked to 9/11 exposure, for significant assessment of comorbidities, and to explore possibilities for study recruitment to meet researcher needs. 19. Providing analytic support to the WTC Program Administrator when information is required by governmental accountability entities; and 20. Facilitating the coordination of outreach and retention activities of the corresponding CCEs. NIOSH is responsible for creating an outreach and retention strategy for the WTC Health Program that is applicable to all cohorts and at the national and local level. Program-wide outreach activities will be coordinated through a NIOSH point of contact, with assistance from the DCs in synchronizing activities within their cohort. The DCs activities in outreach and retention coordination should be approved by NIOSH and should be limited to efforts to assist the CCEs in a manner to enhance communication, transparency, cooperation, and avoidance of duplication of efforts when engaging the relevant cohort. Coordination activities also include engaging all CCEs for planning cohort-wide events or fostering CCE participation in outreach and retention activities in the local NYC-area for the cohort. At the awarding of this contract, each CCE will be given an opportunity to provide input on how best to define the role of the DC in coordinating activities to meet the needs of all CCEs. Evaluation activities will be coordinated with NIOSH, with reports available on request.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/CMBP/WTCHPDC-2017-00641/listing.html)
- Place of Performance
- Address: USA, United States
- Record
- SN04191812-W 20160723/160721235938-df5fcfcb8297701db1e52a6b3eecdde2 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |